Is MDxHealth SA halal to invest in?

According to Musaffa's Shariah screening methodology, MDxHealth SA (MDXH) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is MDxHealth SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes MDxHealth SA using these criteria to determine its compliance status.

Can Muslims buy shares of MDxHealth SA?

Muslim investors may consider investing in MDxHealth SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is MDxHealth SA classified as NOT HALAL?

Musaffa determines the Shariah status of MDxHealth SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for MDxHealth SA updated?

The Shariah compliance status of MDxHealth SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like MDxHealth SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of MDxHealth SA?

You can check the latest Shariah compliance status of MDxHealth SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MDXH Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 30, 2026

Report Source: 2025 Annual Report

MDxHealth SA. Stock Analysis MDXH

United States Health Care Micro Cap Report: 2025 Annual

MDxHealth SA is a commercial-stage precision diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The firm's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.

Key Statistics of MDxHealth SA (MDXH)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.68$0.98

Today's Open

$0.98

Volume

3.28M

P/E Ratio (TTM)

52 Week Range

$0.68$5.33

Market Cap

102.73M

Avg. Volume

847.56K

Dividend Yield

Financial Metrics & Statements of MDxHealth SA (MDXH)

FAQ's for MDxHealth SA (MDXH)

According to Musaffa’s Shariah screening methodology, MDxHealth SA (MDXH) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.